Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The CCR5Delta32 allele is associated with reduced liver inflammation in hepatitis C virus infection.

European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics - 1 Dec 2004

Wald O, Pappo O, Ari Z B, Azzaria E, Wiess I D, Gafnovitch I, Wald H, Spengler U, Galun E, Peled A

Abstract excerpt

CCR5Delta32 is a deletion mutation in the chemokine receptor CCR5. Liver inflammatory activity was found to be significantly reduced (P = 0.005) in Jewish Israeli patients infected with the hepatitis C virus (HCV) carrying the CCR5Delta32 allele. The CCR5Delta32 allele does not alter susceptibili...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over
Share to Hepacivirus

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis C

Share to Heterozygote

Share to Inflammation

Share to Receptors, CCR5

Source

Identifiers

PMID: 15548261
DOI: 10.1111/j.1365-2370.2004.00482.x

Genes

CCR5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-15548261-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The CCR5Delta32 allele is associated with reduced liver inflammation in hepatitis C virus infection.PMID 15548261Read ↗

Clinical significance of the CCR5delta32 allele in hepatitis C.Semantic proximity Read ↗

CCR5Delta32 mutation does not influence the susceptibility to HCV infection, severity of liver disease and response to therapy in patients with chronic hepatitis C.Semantic proximity Read ↗

Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C.Semantic proximity Read ↗

The CCR5-delta32 mutation: impact on disease outcome in individuals with hepatitis C infection from a single source.Semantic proximity Read ↗

Effects of the CCR5-Delta32 mutation on antiviral treatment in chronic hepatitis C.Semantic proximity Read ↗

Frequency of the HIV-protective CC chemokine receptor 5-Delta32/Delta32 genotype is increased in hepatitis C.Semantic proximity Read ↗

Effects of the CCR5-Delta32 mutation on hepatitis C virus-specific immune responses in patients with haemophilia.Semantic proximity Read ↗

CC chemokine receptor 5 delta32 polymorphism in two independent cohorts of hepatitis C virus infected patients without hemophilia.Semantic proximity Read ↗

Lack of higher frequency of the chemokine receptor 5-delta32/delta32 genotype in hepatitis C.Semantic proximity Read ↗

CCR5-Delta32 mutation is strongly associated with primary sclerosing cholangitis.Semantic proximity Read ↗

Genetic protection against hepatitis B virus conferred by CCR5Delta32: Evidence that CCR5 contributes to viral persistence.Semantic proximity Read ↗

CCR5-Δ32 genotype does not improve predictive value of IL28B polymorphisms for treatment response in chronic HCV infection.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.